Paradigm Capital Management Inc’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.51M | Hold |
123,100
| – | – | 0.13% | 62 |
|
|
2025
Q4 | $4.87M | Hold |
123,100
| – | – | 0.21% | 56 |
|
|
2025
Q3 | $4.34M | Hold |
123,100
| – | – | 0.19% | 62 |
|
|
2025
Q2 | $4.03M | Hold |
123,100
| – | – | 0.2% | 59 |
|
|
2025
Q1 | $3.97M | Buy |
123,100
+15,800
| +15% | +$587K | 0.22% | 61 |
|
|
2024
Q4 | $3.28M | Hold |
107,300
| – | – | 0.15% | 65 |
|
|
2024
Q3 | $3.01M | Hold |
107,300
| – | – | 0.13% | 75 |
|
|
2024
Q2 | $2.44M | Buy |
107,300
+10,000
| +10% | +$231K | 0.11% | 78 |
|
|
2024
Q1 | $2.96M | Buy |
97,300
+2,450
| +3% | +$82.1K | 0.14% | 72 |
|
|
2023
Q4 | $3.39M | Buy |
94,850
+7,650
| +9% | +$285K | 0.18% | 63 |
|
|
2023
Q3 | $3.82M | Hold |
87,200
| – | – | 0.22% | 61 |
|
|
2023
Q2 | $4.3M | Hold |
87,200
| – | – | 0.25% | 57 |
|
|
2023
Q1 | $3.61M | Hold |
87,200
| – | – | 0.24% | 61 |
|
|
2022
Q4 | $3.87M | Hold |
87,200
| – | – | 0.26% | 72 |
|
|
2022
Q3 | $3.41M | Hold |
87,200
| – | – | 0.25% | 71 |
|
|
2022
Q2 | $3.56M | Hold |
87,200
| – | – | 0.24% | 75 |
|
|
2022
Q1 | $5.73M | Hold |
87,200
| – | – | 0.31% | 70 |
|
|
2021
Q4 | $6.06M | Hold |
87,200
| – | – | 0.27% | 73 |
|
|
2021
Q3 | $6.07M | Hold |
87,200
| – | – | 0.31% | 73 |
|
|
2021
Q2 | $6.92M | Hold |
87,200
| – | – | 0.33% | 67 |
|
|
2021
Q1 | $5.71M | Hold |
87,200
| – | – | 0.3% | 69 |
|
|
2020
Q4 | $4.85M | Hold |
87,200
| – | – | 0.29% | 71 |
|
|
2020
Q3 | $3.48M | Hold |
87,200
| – | – | 0.29% | 72 |
|
|
2020
Q2 | $3.92M | Hold |
87,200
| – | – | 0.36% | 62 |
|
|
2020
Q1 | $2.93M | Sell |
87,200
-90,000
| -51% | -$3.24M | 0.35% | 66 |
|
|
2019
Q4 | $5.76M | Buy |
177,200
+5,000
| +3% | +$142K | 0.44% | 57 |
|
|
2019
Q3 | $4.29M | Buy |
172,200
+105,000
| +156% | +$3M | 0.38% | 64 |
|
|
2019
Q2 | $2M | Buy |
67,200
+26,800
| +66% | +$782K | 0.18% | 92 |
|
|
2019
Q1 | $1.08M | Hold |
40,400
| – | – | 0.1% | 114 |
|
|
2018
Q4 | $1.24M | Hold |
40,400
| – | – | 0.12% | 109 |
|
|
2018
Q3 | $1.42M | Sell |
40,400
-10,000
| -20% | -$317K | 0.11% | 113 |
|
|
2018
Q2 | $1.36M | Sell |
50,400
-60,000
| -54% | -$1.41M | 0.11% | 106 |
|
|
2018
Q1 | $2.27M | Buy |
110,400
+70,400
| +176% | +$1.27M | 0.19% | 83 |
|
|
2017
Q4 | $729K | Hold |
40,000
| – | – | 0.06% | 127 |
|
|
2017
Q3 | $895K | Sell |
40,000
-925
| -2% | -$20.9K | 0.08% | 125 |
|
|
2017
Q2 | $992K | Hold |
40,925
| – | – | 0.09% | 119 |
|
|
2017
Q1 | $783K | Sell |
40,925
-87,600
| -68% | -$1.53M | 0.07% | 125 |
|
|
2016
Q4 | $2.52M | Sell |
128,525
-205,900
| -62% | -$3.73M | 0.24% | 81 |
|
|
2016
Q3 | $5.29M | Buy |
334,425
+5,200
| +2% | +$79.9K | 0.56% | 54 |
|
|
2016
Q2 | $4.65M | Sell |
329,225
-51,900
| -14% | -$791K | 0.57% | 51 |
|
|
2016
Q1 | $6.41M | Buy |
381,125
+133,600
| +54% | +$2.35M | 0.75% | 42 |
|
|
2015
Q4 | $5.55M | Buy |
247,525
+128,700
| +108% | +$2.65M | 0.62% | 48 |
|
|
2015
Q3 | $2.6M | Buy |
118,825
+1,400
| +1% | +$35K | 0.32% | 79 |
|
|
2015
Q2 | $2.89M | Buy |
117,425
+5,125
| +5% | +$114K | 0.3% | 83 |
|
|
2015
Q1 | $2.3M | Hold |
112,300
| – | – | 0.24% | 90 |
|
|
2014
Q4 | $2.24M | Hold |
112,300
| – | – | 0.22% | 97 |
|
|
2014
Q3 | $1.65M | Hold |
112,300
| – | – | 0.14% | 133 |
|
|
2014
Q2 | $2.06M | Buy |
+112,300
| New | +$1.87M | 0.15% | 132 |
|
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
Paradigm Capital Management Inc's ATRC Position: Q1 2026 in Review
Paradigm Capital Management Inc held its AtriCure (ATRC) position steady in Q1 2026 at 123,100 shares worth $3.51M. The position accounts for 0.13% of the portfolio, ranked #62.
Paradigm Capital Management Inc first reported a position in ATRC in Q2 2014 and has held it in 48 quarters since. The position peaked at $6.92M in Q2 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Paradigm Capital Management Inc held 123,100 shares of AtriCure worth $3.51M as of Q1 2026.
- Paradigm Capital Management Inc left its AtriCure share count unchanged in Q1 2026.
- AtriCure made up 0.13% of Paradigm Capital Management Inc's portfolio in Q1 2026, its #62 holding.
- Paradigm Capital Management Inc first reported a position in AtriCure in Q2 2014 and has held it in 48 quarters since.
- Paradigm Capital Management Inc's AtriCure position peaked at $6.92M in Q2 2021.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Paradigm Capital Management Inc's 13F filing for Q1 2026, filed 14 May 2026.